Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

SIMPLE SUMMARY: We investigated the efficacy of liver-directed concurrent chemoradiotherapy compared with sorafenib in hepatocellular carcinoma patients with portal vein tumor thrombosis. Patients in the sorafenib group presented higher incidences of unfavorable clinical features, and propensity sco...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jina, Byun, Hwa Kyung, Kim, Tae Hyung, Kim, Sun Il, Kim, Beom Kyung, Kim, Seung Up, Park, Jun Yong, Kim, Do Young, Seong, Jinsil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139919/
https://www.ncbi.nlm.nih.gov/pubmed/35626001
http://dx.doi.org/10.3390/cancers14102396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139919/
https://www.ncbi.nlm.nih.gov/pubmed/35626001
http://dx.doi.org/10.3390/cancers14102396

Ejemplares similares